As marketers, we often wonder how we can best get our concept and product information to our customers, while maintaining the integrity of our marketing communication and avoiding any dilut
Roche has beaten analysts’ revenue forecasts in the third quarter, after mounting sales of its older drugs in China and the success of newer drugs mitigated the impact of patent expiries.
Roche has been shocked by the late-stage trial failure of its immunotherapy Tecentriq in bladder cancer, a setback which could cost it billions if the drug loses its licence.
